| JYHZ2200058 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2022-03-04 | | | | | view |
| JYHZ2200057 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2022-03-04 | | | | | view |
| JYHZ2200056 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2022-03-04 | | | | | view |
| JYHZ2200055 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2022-03-04 | | | | | view |
| JYHZ1600340 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2017-02-06 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Approval Completed-Pending Certificated | 2017-09-21 | view |
| JYHZ1600339 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2017-02-06 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Approval Completed-Pending Certificated | 2017-09-21 | view |
| JYHZ1600338 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2017-01-09 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Approval Completed-Pending Certificated | 2017-09-21 | view |
| JYHZ1600337 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2017-01-09 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Approval Completed-Pending Certificated | 2017-09-21 | view |
| JYHZ1200068 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2012-05-09 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2013-05-16 | view |
| JYHZ1200067 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2012-05-09 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2013-05-16 | view |
| JYHZ1200066 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2012-05-09 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2013-05-16 | view |
| JYHZ1200065 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | License Renew | 2012-05-14 | 辉瑞制药有限公司 | Pfizer Pharmaceuticals Ltd | Certificate Issued | 2013-05-16 | view |
| JYHS2200003 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs(5.2) | Import Drug Application | 2022-01-17 | | | | | view |
| JYHB2200038 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2022-01-18 | | | | | view |
| JYHB2200037 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2022-01-18 | | | | | view |
| JYHB2200036 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2022-01-18 | | | | | view |
| JYHB2200035 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2022-01-18 | | | | | view |
| JYHB2100039 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2021-01-08 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2021-01-07 | view |
| JYHB2100038 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2021-01-19 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2021-01-18 | view |
| JYHB2100037 | 苹果酸舒尼替尼胶囊 | Sunitinib Malate | Capsule | Chemical Drugs | Supplementary Application | 2021-01-19 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | In Review | 2021-01-18 | view |
